Latest news
Celldex Therapeutics (CLDX) Stock Looks Rich On Book Value But Strong On Returns - simplywall.stsimplywall.st · Sun, 09 Aug 2026 06:38:58 GMTCelldex Therapeutics (CLDX) Could Be 130% Undervalued After Second Quarter Results - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 06:13:00 GMTWhat Is Celldex Therapeutics (CLDX) Signaling With Its Mixed Pipeline Update? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 21:15:24 GMTCelldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:10:20 GMTCelldex Therapeutics (NASDAQ: CLDX) ramps barzolvolimab spend, raises $324M - Stock TitanStock Titan · Thu, 06 Aug 2026 20:08:23 GMTWhy Celldex Therapeutics (CLDX) Is Up 7.9% After Phase 2 Prurigo Nodularis Results And What's Next - webull.comwebull.com · Tue, 04 Aug 2026 02:01:56 GMTCelldex Therapeutics (CLDX) After Phase 2 Trial Results As Valuation Questions Come Into Focus - simplywall.stsimplywall.st · Fri, 31 Jul 2026 19:21:59 GMT